WORK Medical Technology Group (NASDAQ: WOK) is a China-based medical device company specializing in the research, development, manufacturing and distribution of orthopedic implants and related surgical instruments. Since its founding in 2009, the company has focused on delivering products for trauma fixation, spine surgery, joint reconstruction and sports medicine. Its portfolio includes plates, screws, intramedullary nails, artificial joints and minimally invasive surgical tools designed to meet the needs of hospitals and outpatient surgical centers.
The company operates through a vertically integrated model, combining in-house manufacturing capabilities with an extensive sales and distribution network. Its production facilities are located in Ningbo, Zhejiang Province, where it maintains quality control, engineering and product development teams. WORK Medical Technology Group also leverages a proprietary e-commerce platform to serve smaller clinics and rural healthcare providers, providing a direct channel for product ordering and technical support.
Geographically, WORK Medical Technology Group primarily serves hospitals and distributors across Mainland China, with growing export operations in Southeast Asia and select markets in Europe. Its domestic sales team collaborates closely with orthopedic surgeons, trauma specialists and hospital procurement departments to tailor product offerings and training programs. On the export side, the company works with regional partners and distributors to navigate local regulatory requirements and ensure timely delivery of its devices.
Leadership at WORK Medical Technology Group is headed by CEO Yunni Wang, who has overseen the company’s expansion into advanced implant technologies and e-commerce distribution channels. The management team includes experienced professionals in regulatory affairs, manufacturing, quality assurance and clinical affairs, all of whom contribute to a strategic focus on innovation and compliance with international medical device standards. Through ongoing investment in R&D and strategic partnerships, the company aims to broaden its product range and strengthen its position in both domestic and international orthopedic markets.
AI Generated. May Contain Errors.
